注册以创建品种、
财经事件和所关注作者内容的提醒
免费注册 已有账户? 登录
华润医药集团有限公司是一家香港投资控股公司。该公司及其子公司主要从事医药及其他保健品的研发、制造、分销及零售业务。该公司主要通过三大分部运营。制药分部研发、制造及销售医药及营养保健品。医药分销分部向医药制造商及配药商提供分销解决方案,如医院及其他医疗机构、分销商及零售药店。药品零售分部在中国及香港经营零售药店。
名称 | 年龄 | 任期 | 标题 |
---|---|---|---|
Zhongliang Yu | 56 | 2016 | Non-Executive Director |
Chuncheng Wang | 58 | 2014 | Non-Executive Chairman |
Xiangming Li | 56 | 2012 | Executive Vice Chairman of the Board |
Yuewei Han | 55 | 2019 | Chairman |
Xiaosong Bai | 51 | 2022 | CEO & Executive Director |
Ruifang Jiao | 45 | 2022 | Non-Executive Director |
Tingmei Fu | 58 | 2016 | Independent Non-Executive Director |
Ran Tao | 59 | 2021 | VP & Executive Director |
Kin Fun Kwok | 74 | 2016 | Independent Non-Executive Director |
Wei Guo | 46 | 2023 | Non-Executive Director |
Kejian Zhang | 68 | 2016 | Independent Non-Executive Director |
Mo Han Shing | 69 | 2017 | Independent Non-Executive Director |
Yi Feng | 62 | 2015 | Chairman of China Resources Double-Crane Pharmaceutical Co., Ltd. |
Bo Hou | 59 | 2021 | Non-Executive Director |
Rong Deng | 46 | 2023 | CFO & Executive Director |
Yongqiang Sun | 53 | 2023 | Non-Executive Director |
确定屏蔽%USER_NAME%?
如果屏蔽,您和%USER_NAME%都无法看到相互在Investing.com上发布的信息。
%USER_NAME%已成功添加至屏蔽列表
由于您刚刚取消屏蔽此人,因此必须等待48小时才能重新屏蔽。
您举报该评论的原因为:
谢谢您!
您的举报将会被发送到管理员进行审核